Clinical Report: The Role of Gut Microbiota in Colorectal Cancer

Background

Colorectal cancer is a leading cause of cancer-related morbidity and mortality globally. The gut microbiota significantly influences CRC through its interactions with the immune system and inflammatory processes.

Data Highlights

No specific numerical or trial data provided in the source material.

Key Findings

• Dysbiosis of the gut microbiota can lead to persistent inflammatory signaling and aberrant cytokine production.
• Alterations in gut microbiota contribute to epithelial injury and chronic inflammation, which are critical in tumor initiation and progression.
• Microbial metabolites can activate key signaling pathways that modulate immune responses and tumor-promoting inflammation.
• Current evidence on the role of gut microbiota in CRC is primarily derived from preclinical models.
• Emerging therapeutic strategies are focusing on the microbiota–immune axis.

Clinical Implications

Understanding the interactions between gut microbiota and the immune system may lead to new diagnostic and therapeutic approaches for CRC.

Conclusion

Continued research is essential to explore the role of gut microbiota in colorectal cancer.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- The relationship between Gut Microbiota and Cancer Immune Response and Immunotherapy
2. Journal of Gastrointestinal Surgery, 2023 -- Disruption of Gut Barrier Integrity and the Role of Bacterial Lipopolysaccharides in Colorectal Cancer
3. Frontiers in Immunology, 2026 -- Multidimensional exploration of the relationship between gut microbiota and colorectal cancer: focus on clinical tumorigenesis and treatment
4. The ASCO Post — Decreased Diversity of Gut Bacteria Associated With  Risk of Colorectal Cancer
5. NCCN Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening
6. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for gastrointestinal cancer
7. International consensus statement on microbiome testing in clinical practice
8. Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer | Nature Medicine
9. Meta-analysis reveals microbiome signatures for colorectal cancer that are universal across age groups and sequencing methods - PubMed
10. Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic review | British Journal of Cancer
11. Clostridium butyricum MIYAIRI 588 Reduces Colorectal Adenomatous Polyp Recurrence: A Randomized Crossover Trial - PubMed
12. The gut microbiome and colorectal cancer | Clinical Microbiology Reviews
13. The microbiota–metabolite–immune axis in colorectal cancer: mechanistic insights and emerging clinical applications
14. The immune microenvironment of colorectal cancer | Nature Reviews Cancer